NantHealth, Inc, together with its subsidiaries, operates as a healthcare technology company in the United States and internationally. The company engages in converging science and technology through an integrated clinical platform to provide health information at the point of care. It develops NantHealth solutions, including molecular profiling solutions, software, and hardware systems infrastructure, which integrates patient data management, bioinformatics, and molecular medicine to enable value-based care and evidence-based clinical practice.
Read More…
Industry, Sector and Symbol
Industry Data processing & preparation
Sub-IndustryN/A
SectorMedical
Phone310-883-1300
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$89.46 million
Profitability
Miscellaneous
Employees543
Next Earnings Date11/21/2019 (Estimated)
OptionableOptionable
NantHealth (NASDAQ:NH) Frequently Asked Questions
What is NantHealth's stock symbol?
NantHealth trades on the NASDAQ under the ticker symbol "NH."
How were NantHealth's earnings last quarter?
NantHealth Inc (NASDAQ:NH) issued its quarterly earnings data on Thursday, August, 8th. The company reported ($0.13) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.12) by $0.01. The firm had revenue of $25.69 million for the quarter, compared to analysts' expectations of $24 million. NantHealth had a negative net margin of 191.63% and a negative return on equity of 10,113.15%. View NantHealth's Earnings History.
When is NantHealth's next earnings date?
What price target have analysts set for NH?
1 equities research analysts have issued 12 month price objectives for NantHealth's shares. Their forecasts range from $1.00 to $1.00. On average, they expect NantHealth's stock price to reach $1.00 in the next twelve months. This suggests a possible upside of 40.8% from the stock's current price. View Analyst Price Targets for NantHealth.
What is the consensus analysts' recommendation for NantHealth?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for NantHealth in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for NantHealth.
Has NantHealth been receiving favorable news coverage?
Media coverage about NH stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of press coverage by reviewing more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. NantHealth earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the immediate future. View News Stories for NantHealth.
Are investors shorting NantHealth?
NantHealth saw a decrease in short interest during the month of September. As of September 30th, there was short interest totalling 773,900 shares, a decrease of 19.0% from the August 30th total of 955,600 shares. Based on an average daily volume of 105,600 shares, the days-to-cover ratio is currently 7.3 days. Approximately 2.4% of the company's shares are short sold. View NantHealth's Current Options Chain.
Who are some of NantHealth's key competitors?
Some companies that are related to NantHealth include GTY Technology (GTYH), Ooma (OOMA), Castlight Health (CSLT), Fang (SFUN), FRONTEO (FTEO), Park City Group (PCYG), Phunware (PHUN), Veritone (VERI), Renren (RENN), Innodata (INOD), Support.com (SPRT), Data Storage (DTST), ChinaCache International (CCIH), Net Element (NETE) and Marin Software (MRIN).
What other stocks do shareholders of NantHealth own?
Who are NantHealth's key executives?
NantHealth's management team includes the folowing people:
- Dr. Patrick Soon-Shiong F.A.C.S., FRCS (C), M.D., FACS, Founder, Chairman & CEO (Age 66)
- Mr. Ronald Allen Louks, COO & Director (Age 54)
- Mr. Bob Petrou, Interim Chief Financial Officer (Age 47)
- Mr. Brandon Villery, VP, Gen. Counsel & Corp. Sec.
- Mr. Charles Hunt, VP of Marketing, Communications & User Experience
When did NantHealth IPO?
(NH) raised $91 million in an IPO on Thursday, June 2nd 2016. The company issued 6,500,000 shares at a price of $12.50-$15.50 per share. Jefferies and Cowen and Company acted as the underwriters for the IPO and First Analysis Securities, Canaccord Genuity and FBR were co-managers.
How do I buy shares of NantHealth?
Shares of NH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is NantHealth's stock price today?
One share of NH stock can currently be purchased for approximately $0.71.
How big of a company is NantHealth?
NantHealth has a market capitalization of $78.57 million and generates $89.46 million in revenue each year. The company earns $-192,150,000.00 in net income (profit) each year or ($1.74) on an earnings per share basis. NantHealth employs 543 workers across the globe.View Additional Information About NantHealth.
What is NantHealth's official website?
How can I contact NantHealth?
NantHealth's mailing address is 9920 JEFFERSON BLVD, CULVER CITY CA, 90232. The company can be reached via phone at 310-883-1300 or via email at [email protected]
MarketBeat Community Rating for NantHealth (NASDAQ NH)
MarketBeat's community ratings are surveys of what our community members think about NantHealth and other stocks. Vote "Outperform" if you believe NH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NH will underperform the S&P 500 over the long term. You may vote once every thirty days.
